Woebot Health

Woebot Health is an AI-powered mental health technology company that delivers evidence-based cognitive behavioral therapy through an intelligent chatbot interface. Their flagship product uses conversational AI to guide users through therapeutic techniques designed to manage anxiety, depression, and stress in real time. By combining natural language processing with clinically validated CBT methodologies, Woebot creates an accessible, on-demand mental health support tool that meets users where they are. The platform operates as a scalable alternative to traditional therapy, enabling personalized therapeutic interventions available 24/7.

Founded and headquartered in San Francisco, Woebot Health has established itself as a leader in the mental health tech space, securing Series B funding of $90 million to accelerate product development and market expansion. The company has achieved significant traction with users and healthcare partners, demonstrating the commercial viability of AI-driven mental health interventions. Their funding milestone reflects investor confidence in both the company's technology and the growing demand for digital mental health solutions in clinical and consumer markets.

Woebot Health represents a meaningful advancement in neurotechnology by democratizing access to evidence-based mental health treatment at scale. Their work bridges the gap between artificial intelligence and neuroscience by operationalizing therapeutic principles through technology, addressing a critical gap in mental health care accessibility. As mental health disorders continue to affect millions globally, Woebot's approach models how neurotechnology can deliver clinically sound, personalized interventions that complement traditional care pathways and expand mental health support beyond traditional therapy limitations.